Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Recent progress in lymphoma classification

G Frizzera1

  • 1New York University Medical Center, Department of Pathology, NY 10016, USA.

Current Opinion in Oncology
|November 5, 1997
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Brief-duration high-intensity chemotherapy for patients with small noncleaved-cell lymphoma or FAB L3 acute lymphocytic leukemia: results of cancer and leukemia group B study 9251.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2001
Same author

Interferon-alpha activity in a case of severe autoimmune lymphoproliferative disease.

Annals of hematology·2001
Same author

Increased proteasome degradation of cyclin-dependent kinase inhibitor p27 is associated with a decreased overall survival in mantle cell lymphoma.

Blood·2000
Same author

Mediastinal large B-cell lymphoma vs classic Hodgkin lymphoma.

American journal of clinical pathology·1999
Same author

Detection of immunoglobulin kappa light chain rearrangements by polymerase chain reaction. An improved method for detecting clonal B-cell lymphoproliferative disorders.

The American journal of pathology·1999
Same author

Extramedullary plasmacytoma. A form of marginal zone cell lymphoma?

American journal of clinical pathology·1999
Same journal

Artificial intelligence-augmented robotic surgery in gynecologic oncology: intraoperative assistance and analytics.

Current opinion in oncology·2026
Same journal

Artificial intelligence in cervical cancer screening and triage: a role-stratified systematic review and bivariate meta-analysis.

Current opinion in oncology·2026
Same journal

Deep learning assisting the surgical management of gynecologic cancers.

Current opinion in oncology·2026
Same journal

Pain management in pancreatic cancer: time to change our strategy!

Current opinion in oncology·2026
Same journal

Systemic radionuclide treatments in gastro-entero-pancreatic neuroendocrine tumours.

Current opinion in oncology·2026
Same journal

5-Fluorouracil at seventy: still attractive but barely understood. A cautionary tale for drug development.

Current opinion in oncology·2026
See all related articles

The International Lymphoma Study Group

Area of Science:

  • Hematopathology and Lymphoid Neoplasms
  • Oncology
  • Immunology

Background:

  • The Revised European-American classification provides a comprehensive list of lymphoid neoplasms.
  • This classification consolidates recognized B-cell, T/natural killer (NK)-cell lymphomas, leukemias, and Hodgkin's disease variants.
  • A key challenge is to make this complex information accessible for education and clinical practice.

Purpose of the Study:

  • To define and collect disease entities within the B-cell and T/NK-cell lymphomas and leukemias.
  • To establish a foundation for a clinically meaningful classification of lymphoid neoplasms.
  • To discuss potential future revisions based on emerging data and clinical relevance.

Main Methods:

  • Compilation and definition of lymphoid neoplasm entities based on the International Lymphoma Study Group's revised list.

Related Experiment Videos

  • Review of existing literature and recent data to validate and refine classifications.
  • International consensus among clinicians to build a clinically applicable classification system.

    • Main Results:

    • A standardized list of lymphoid neoplasms is established, serving as a foundation for classification.
    • Clinical data largely support the validity of many categories within the proposed classification.
    • Areas requiring further refinement include lymphoplasmacytic lymphoma, mantle-cell lymphoma variants, marginal zone B-cell lymphomas, large B-cell lymphomas, and NK-cell lymphomas.

    Conclusions:

    • The proposed classification by the International Lymphoma Study Group is robust and intended for long-term use.
    • Ongoing research and clinical data necessitate discussions on potential additions and modifications to the classification.
    • Future efforts should focus on refining specific lymphoma categories for improved understanding and clinical application.